My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 5 results for

GO
Search Filters: Policy cancel New York cancel Vermont cancel Utah cancel

Domestic Holiday Travel Pandemic Restrictions and Recommendations

Blog,
Health Policy Update,
Infectious Disease,
COVID-19,
COVID and Community Mitigation,
COVID and Law/Policy,
COVID Preparedness,
Health Equity,
Tribal Health,
Preparedness,
Emergency Powers,
Policy,
State Health Policy,
Territories and Freely Associated States,
Alabama,
Alaska,
American Samoa,
Arizona,
Arkansas,
California,
Colorado,
Connecticut,
Delaware,
Washington, D.C.,
Federated States of Micronesia,
Florida,
Georgia,
Guam,
Hawaii,
Idaho,
Illinois,
Indiana,
Iowa,
Kansas,
Kentucky,
Louisiana,
Maine,
Marshall Islands,
Maryland,
Massachusetts,
Michigan,
Minnesota,
Mississippi,
Missouri,
Montana,
Nebraska,
Nevada,
New Hampshire,
New Jersey,
New Mexico,
New York,
North Carolina,
North Dakota,
Northern Mariana Islands,
Ohio,
Oklahoma,
Oregon,
Palau,
Pennsylvania,
Puerto Rico,
Rhode Island,
South Carolina,
South Dakota,
Tennessee,
Texas,
Utah,
Vermont,
Virgin Islands,
Virginia,
Washington,
West Virginia,
Wisconsin,
Wyoming,
Maggie Davis

The 2020 holiday season is coinciding with a nationwide surge of COVID-19 cases. With great concern that holiday travel to see loved ones may exacerbate community spread of the virus, many states are increasing public health measures ...

The Impact of Non-Medical Vaccine Exemptions on Childhood Vaccination Rates

Blog,
Health Policy Update,
Infectious Disease,
Immunization,
Vaccine Hesitancy,
Policy,
State Health Policy,
Arizona,
Arkansas,
Georgia,
Iowa,
Massachusetts,
Minnesota,
Mississippi,
Montana,
Nebraska,
New Mexico,
New York,
Ohio,
Oregon,
Rhode Island,
Utah,
Vermont,
Virginia,
West Virginia,
Heather Tomlinson

As many state legislatures seek to expand vaccine exemptions, it’s important to understand the fundamental differences in exemption type and their impact on a community.

2023 Legislative Session Update: Part One

Blog,
Health Policy Update,
Policy,
State Health Policy,
Territorial Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Mental Health,
STIs,
HIV,
Substance Misuse,
Opioids,
Tobacco Control,
Environmental Health,
Food and Water Safety,
PFAS,
Florida,
Guam,
Hawaii,
Illinois,
Indiana,
Kentucky,
Mississippi,
New Mexico,
New York,
Oklahoma,
South Dakota,
Utah,
Vermont,
Virginia,
West Virginia,
Beth Giambrone,
Christina Severin,
Parker Beene,
Maggie Davis

A mid-session legislative update on five of ASTHO's top 10 public health state policy issues to watch in 2023: tobacco, HIV, mental health, PFAS, and opioids.

States Take Action to Expand Access to PrEP Through Telehealth

Blog,
Health Policy Update,
Health Equity,
At-Risk Populations,
Population Health and Prevention,
Social and Behavioral Health,
STIs,
HIV,
Healthcare Access,
Primary Care and Public Health,
Telehealth,
Medicaid and Public Health Partnerships,
Iowa,
Louisiana,
Michigan,
New Jersey,
New York,
Utah,
Vermont,
Tequam Worku,
Policy,
Federal Government Affairs,
State Health Policy,
Race and Public Health,
LGBTQ+,
Substance Misuse,
Partnership

State and local jurisdictions are developing Ending the HOV Epidemic plans. The EHE initiative has largely focused on four key strategies: Diagnose, Treat, Prevent, and Respond to potential outbreaks. The EHE initiative set a goal to ...

How the Emergence of Xylazine Impacts Overdose Prevention Policy

Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Blog,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...